nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—Nucleic Acid Synthesis Inhibitors—Azathioprine—systemic lupus erythematosus	0.661	1	CiPCiCtD
Gemcitabine—ABCC10—Cyclosporine—systemic lupus erythematosus	0.0601	0.326	CbGbCtD
Gemcitabine—TYMS—Methotrexate—systemic lupus erythematosus	0.0386	0.209	CbGbCtD
Gemcitabine—ABCC10—Methotrexate—systemic lupus erythematosus	0.0318	0.173	CbGbCtD
Gemcitabine—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.00974	0.0529	CbGbCtD
Gemcitabine—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.00738	0.0401	CbGbCtD
Gemcitabine—ABCB1—Betamethasone—systemic lupus erythematosus	0.00634	0.0344	CbGbCtD
Gemcitabine—ABCB1—Prednisolone—systemic lupus erythematosus	0.00625	0.0339	CbGbCtD
Gemcitabine—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00593	0.0322	CbGbCtD
Gemcitabine—ABCB1—Prednisone—systemic lupus erythematosus	0.0059	0.032	CbGbCtD
Gemcitabine—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0056	0.0304	CbGbCtD
Gemcitabine—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00369	0.02	CbGbCtD
Gemcitabine—ABCB1—Methotrexate—systemic lupus erythematosus	0.00296	0.0161	CbGbCtD
Gemcitabine—Cytarabine—POLB—systemic lupus erythematosus	0.0021	1	CrCbGaD
Gemcitabine—SLC28A1—nephron tubule—systemic lupus erythematosus	0.00162	0.0376	CbGeAlD
Gemcitabine—SLC28A1—kidney—systemic lupus erythematosus	0.00143	0.0331	CbGeAlD
Gemcitabine—SLC28A1—cortex of kidney—systemic lupus erythematosus	0.00139	0.0322	CbGeAlD
Gemcitabine—POLD1—skin of body—systemic lupus erythematosus	0.00101	0.0234	CbGeAlD
Gemcitabine—CMPK1—connective tissue—systemic lupus erythematosus	0.000891	0.0206	CbGeAlD
Gemcitabine—CMPK1—nephron tubule—systemic lupus erythematosus	0.000863	0.02	CbGeAlD
Gemcitabine—POLD1—lymphoid tissue—systemic lupus erythematosus	0.000816	0.0189	CbGeAlD
Gemcitabine—CMPK1—skin of body—systemic lupus erythematosus	0.000804	0.0186	CbGeAlD
Gemcitabine—CMPK1—kidney—systemic lupus erythematosus	0.000758	0.0176	CbGeAlD
Gemcitabine—CMPK1—cortex of kidney—systemic lupus erythematosus	0.000739	0.0171	CbGeAlD
Gemcitabine—CDA—lymphoid tissue—systemic lupus erythematosus	0.000733	0.017	CbGeAlD
Gemcitabine—POLE—cortex of kidney—systemic lupus erythematosus	0.000692	0.016	CbGeAlD
Gemcitabine—CDA—tendon—systemic lupus erythematosus	0.000689	0.016	CbGeAlD
Gemcitabine—SLC28A3—bone marrow—systemic lupus erythematosus	0.000682	0.0158	CbGeAlD
Gemcitabine—POLD1—lung—systemic lupus erythematosus	0.000674	0.0156	CbGeAlD
Gemcitabine—CDA—bone marrow—systemic lupus erythematosus	0.000667	0.0155	CbGeAlD
Gemcitabine—CMPK1—lymphoid tissue—systemic lupus erythematosus	0.000651	0.0151	CbGeAlD
Gemcitabine—SLC29A2—tendon—systemic lupus erythematosus	0.000644	0.0149	CbGeAlD
Gemcitabine—RRM2—skin of body—systemic lupus erythematosus	0.000621	0.0144	CbGeAlD
Gemcitabine—SLC28A3—lung—systemic lupus erythematosus	0.000618	0.0143	CbGeAlD
Gemcitabine—POLE—lymphoid tissue—systemic lupus erythematosus	0.00061	0.0141	CbGeAlD
Gemcitabine—CMPK1—bone marrow—systemic lupus erythematosus	0.000593	0.0137	CbGeAlD
Gemcitabine—RRM2—kidney—systemic lupus erythematosus	0.000585	0.0136	CbGeAlD
Gemcitabine—POLE—tendon—systemic lupus erythematosus	0.000574	0.0133	CbGeAlD
Gemcitabine—POLE—bone marrow—systemic lupus erythematosus	0.000556	0.0129	CbGeAlD
Gemcitabine—RRM1—nephron tubule—systemic lupus erythematosus	0.000553	0.0128	CbGeAlD
Gemcitabine—CMPK1—lung—systemic lupus erythematosus	0.000537	0.0124	CbGeAlD
Gemcitabine—TYMS—connective tissue—systemic lupus erythematosus	0.000518	0.012	CbGeAlD
Gemcitabine—RRM1—skin of body—systemic lupus erythematosus	0.000516	0.0119	CbGeAlD
Gemcitabine—POLE—lung—systemic lupus erythematosus	0.000504	0.0117	CbGeAlD
Gemcitabine—RRM2—lymphoid tissue—systemic lupus erythematosus	0.000503	0.0116	CbGeAlD
Gemcitabine—TYMS—nephron tubule—systemic lupus erythematosus	0.000502	0.0116	CbGeAlD
Gemcitabine—CMPK1—nervous system—systemic lupus erythematosus	0.000498	0.0115	CbGeAlD
Gemcitabine—POLA1—tendon—systemic lupus erythematosus	0.000495	0.0115	CbGeAlD
Gemcitabine—RRM1—kidney—systemic lupus erythematosus	0.000486	0.0113	CbGeAlD
Gemcitabine—CMPK1—central nervous system—systemic lupus erythematosus	0.000479	0.0111	CbGeAlD
Gemcitabine—POLA1—bone marrow—systemic lupus erythematosus	0.000479	0.0111	CbGeAlD
Gemcitabine—RRM1—cortex of kidney—systemic lupus erythematosus	0.000474	0.011	CbGeAlD
Gemcitabine—RRM2—tendon—systemic lupus erythematosus	0.000473	0.0109	CbGeAlD
Gemcitabine—TYMS—skin of body—systemic lupus erythematosus	0.000468	0.0108	CbGeAlD
Gemcitabine—POLE—nervous system—systemic lupus erythematosus	0.000466	0.0108	CbGeAlD
Gemcitabine—SLC29A1—connective tissue—systemic lupus erythematosus	0.000464	0.0108	CbGeAlD
Gemcitabine—RRM2—bone marrow—systemic lupus erythematosus	0.000458	0.0106	CbGeAlD
Gemcitabine—POLE—central nervous system—systemic lupus erythematosus	0.000449	0.0104	CbGeAlD
Gemcitabine—POLA1—lung—systemic lupus erythematosus	0.000434	0.0101	CbGeAlD
Gemcitabine—DCK—nephron tubule—systemic lupus erythematosus	0.00043	0.00995	CbGeAlD
Gemcitabine—TYMS—cortex of kidney—systemic lupus erythematosus	0.000429	0.00995	CbGeAlD
Gemcitabine—RRM1—lymphoid tissue—systemic lupus erythematosus	0.000418	0.00967	CbGeAlD
Gemcitabine—RRM2—lung—systemic lupus erythematosus	0.000415	0.00961	CbGeAlD
Gemcitabine—SLC29A1—kidney—systemic lupus erythematosus	0.000395	0.00916	CbGeAlD
Gemcitabine—RRM1—tendon—systemic lupus erythematosus	0.000393	0.00909	CbGeAlD
Gemcitabine—SLC29A1—cortex of kidney—systemic lupus erythematosus	0.000385	0.00892	CbGeAlD
Gemcitabine—RRM2—nervous system—systemic lupus erythematosus	0.000384	0.0089	CbGeAlD
Gemcitabine—RRM1—bone marrow—systemic lupus erythematosus	0.00038	0.00881	CbGeAlD
Gemcitabine—TYMS—lymphoid tissue—systemic lupus erythematosus	0.000379	0.00877	CbGeAlD
Gemcitabine—RRM2—central nervous system—systemic lupus erythematosus	0.00037	0.00856	CbGeAlD
Gemcitabine—DCK—cortex of kidney—systemic lupus erythematosus	0.000368	0.00852	CbGeAlD
Gemcitabine—ABCC10—kidney—systemic lupus erythematosus	0.00036	0.00833	CbGeAlD
Gemcitabine—TYMS—tendon—systemic lupus erythematosus	0.000356	0.00825	CbGeAlD
Gemcitabine—ABCC10—cortex of kidney—systemic lupus erythematosus	0.00035	0.00812	CbGeAlD
Gemcitabine—TYMS—bone marrow—systemic lupus erythematosus	0.000345	0.00799	CbGeAlD
Gemcitabine—RRM1—lung—systemic lupus erythematosus	0.000345	0.00798	CbGeAlD
Gemcitabine—SLC29A1—lymphoid tissue—systemic lupus erythematosus	0.00034	0.00787	CbGeAlD
Gemcitabine—DCK—lymphoid tissue—systemic lupus erythematosus	0.000324	0.00751	CbGeAlD
Gemcitabine—SLC29A1—tendon—systemic lupus erythematosus	0.000319	0.00739	CbGeAlD
Gemcitabine—RRM1—nervous system—systemic lupus erythematosus	0.000319	0.00739	CbGeAlD
Gemcitabine—TYMS—lung—systemic lupus erythematosus	0.000312	0.00724	CbGeAlD
Gemcitabine—SLC29A1—bone marrow—systemic lupus erythematosus	0.000309	0.00716	CbGeAlD
Gemcitabine—ABCC10—lymphoid tissue—systemic lupus erythematosus	0.000309	0.00716	CbGeAlD
Gemcitabine—RRM1—central nervous system—systemic lupus erythematosus	0.000307	0.00711	CbGeAlD
Gemcitabine—DCK—tendon—systemic lupus erythematosus	0.000305	0.00706	CbGeAlD
Gemcitabine—DCK—bone marrow—systemic lupus erythematosus	0.000295	0.00684	CbGeAlD
Gemcitabine—ABCC10—tendon—systemic lupus erythematosus	0.000291	0.00673	CbGeAlD
Gemcitabine—TYMS—nervous system—systemic lupus erythematosus	0.000289	0.0067	CbGeAlD
Gemcitabine—ABCC10—bone marrow—systemic lupus erythematosus	0.000281	0.00652	CbGeAlD
Gemcitabine—SLC29A1—lung—systemic lupus erythematosus	0.00028	0.00649	CbGeAlD
Gemcitabine—TYMS—central nervous system—systemic lupus erythematosus	0.000278	0.00645	CbGeAlD
Gemcitabine—DCK—lung—systemic lupus erythematosus	0.000268	0.0062	CbGeAlD
Gemcitabine—SLC29A1—nervous system—systemic lupus erythematosus	0.000259	0.00601	CbGeAlD
Gemcitabine—ABCC10—lung—systemic lupus erythematosus	0.000255	0.00591	CbGeAlD
Gemcitabine—SLC29A1—central nervous system—systemic lupus erythematosus	0.00025	0.00578	CbGeAlD
Gemcitabine—DCK—nervous system—systemic lupus erythematosus	0.000248	0.00574	CbGeAlD
Gemcitabine—DCK—central nervous system—systemic lupus erythematosus	0.000239	0.00553	CbGeAlD
Gemcitabine—ABCB1—blood plasma—systemic lupus erythematosus	0.000229	0.00531	CbGeAlD
Gemcitabine—POLD1—Danazol—Hydrocortisone—systemic lupus erythematosus	0.00013	0.0611	CbGdCrCtD
Gemcitabine—ABCB1—nephron tubule—systemic lupus erythematosus	0.000118	0.00274	CbGeAlD
Gemcitabine—POLD1—Danazol—Prednisone—systemic lupus erythematosus	0.000112	0.0526	CbGdCrCtD
Gemcitabine—ABCB1—kidney—systemic lupus erythematosus	0.000104	0.00241	CbGeAlD
Gemcitabine—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000101	0.00234	CbGeAlD
Gemcitabine—ABCB1—lymphoid tissue—systemic lupus erythematosus	8.92e-05	0.00207	CbGeAlD
Gemcitabine—ABCB1—bone marrow—systemic lupus erythematosus	8.13e-05	0.00188	CbGeAlD
Gemcitabine—POLA1—Norethindrone—Hydrocortisone—systemic lupus erythematosus	8.04e-05	0.0378	CbGdCrCtD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	7.72e-05	0.00323	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—C4A—systemic lupus erythematosus	7.53e-05	0.00315	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	7.49e-05	0.00313	CbGpPWpGaD
Gemcitabine—POLE—G1 to S cell cycle control—CDKN1A—systemic lupus erythematosus	7.43e-05	0.00311	CbGpPWpGaD
Gemcitabine—ABCB1—lung—systemic lupus erythematosus	7.36e-05	0.00171	CbGeAlD
Gemcitabine—RRM2—E2F transcription factor network—CDKN1A—systemic lupus erythematosus	7.32e-05	0.00306	CbGpPWpGaD
Gemcitabine—RRM2—E2F transcription factor network—EP300—systemic lupus erythematosus	6.96e-05	0.00291	CbGpPWpGaD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—CDKN1B—systemic lupus erythematosus	6.89e-05	0.00288	CbGpPWpGaD
Gemcitabine—ABCB1—nervous system—systemic lupus erythematosus	6.82e-05	0.00158	CbGeAlD
Gemcitabine—SLC28A1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	6.81e-05	0.00284	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—LYN—systemic lupus erythematosus	6.77e-05	0.00283	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—NAT2—systemic lupus erythematosus	6.72e-05	0.00281	CbGpPWpGaD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—CDKN1B—systemic lupus erythematosus	6.61e-05	0.00276	CbGpPWpGaD
Gemcitabine—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	6.59e-05	0.00275	CbGpPWpGaD
Gemcitabine—ABCB1—central nervous system—systemic lupus erythematosus	6.56e-05	0.00152	CbGeAlD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	6.46e-05	0.0027	CbGpPWpGaD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—systemic lupus erythematosus	6.44e-05	0.00269	CbGpPWpGaD
Gemcitabine—POLA1—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	6.4e-05	0.03	CbGdCrCtD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	6.36e-05	0.00266	CbGpPWpGaD
Gemcitabine—POLD1—Synthesis of DNA—CDKN1B—systemic lupus erythematosus	6.33e-05	0.00264	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	6.19e-05	0.00259	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—HIST2H2AC—systemic lupus erythematosus	6.17e-05	0.00258	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—HIST2H2AC—systemic lupus erythematosus	6.13e-05	0.00256	CbGpPWpGaD
Gemcitabine—POLE—Synthesis of DNA—CDKN1B—systemic lupus erythematosus	6.11e-05	0.00255	CbGpPWpGaD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	6.1e-05	0.00255	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	6.09e-05	0.00255	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	6.09e-05	0.00255	CbGpPWpGaD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	5.94e-05	0.00248	CbGpPWpGaD
Gemcitabine—POLD1—DNA Replication—CDKN1B—systemic lupus erythematosus	5.94e-05	0.00248	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—HIST2H2AC—systemic lupus erythematosus	5.92e-05	0.00247	CbGpPWpGaD
Gemcitabine—POLD1—Synthesis of DNA—CDKN1A—systemic lupus erythematosus	5.84e-05	0.00244	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	5.84e-05	0.00244	CbGpPWpGaD
Gemcitabine—RRM2—G1/S Transition—CDKN1B—systemic lupus erythematosus	5.75e-05	0.0024	CbGpPWpGaD
Gemcitabine—POLE—DNA Replication—CDKN1B—systemic lupus erythematosus	5.73e-05	0.0024	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—ADIPOQ—systemic lupus erythematosus	5.73e-05	0.0024	CbGpPWpGaD
Gemcitabine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	5.69e-05	0.00238	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—systemic lupus erythematosus	5.67e-05	0.00237	CbGpPWpGaD
Gemcitabine—POLE—Synthesis of DNA—CDKN1A—systemic lupus erythematosus	5.64e-05	0.00236	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—HIST2H2AC—systemic lupus erythematosus	5.64e-05	0.00236	CbGpPWpGaD
Gemcitabine—SLC29A2—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	5.55e-05	0.00232	CbGpPWpGaD
Gemcitabine—POLE—G1/S Transition—CDKN1B—systemic lupus erythematosus	5.52e-05	0.00231	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—HIST2H2AC—systemic lupus erythematosus	5.51e-05	0.0023	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—HIST2H2AC—systemic lupus erythematosus	5.48e-05	0.00229	CbGpPWpGaD
Gemcitabine—POLD1—DNA Replication—CDKN1A—systemic lupus erythematosus	5.48e-05	0.00229	CbGpPWpGaD
Gemcitabine—POLA1—E2F transcription factor network—CDKN1B—systemic lupus erythematosus	5.42e-05	0.00227	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	5.34e-05	0.00223	CbGpPWpGaD
Gemcitabine—RRM2—G1/S Transition—CDKN1A—systemic lupus erythematosus	5.31e-05	0.00222	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—HIST2H2AC—systemic lupus erythematosus	5.29e-05	0.00221	CbGpPWpGaD
Gemcitabine—POLE—DNA Replication—CDKN1A—systemic lupus erythematosus	5.29e-05	0.00221	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—FOXP3—systemic lupus erythematosus	5.27e-05	0.0022	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—ETS1—systemic lupus erythematosus	5.23e-05	0.00219	CbGpPWpGaD
Gemcitabine—TYMS—E2F transcription factor network—CDKN1B—systemic lupus erythematosus	5.19e-05	0.00217	CbGpPWpGaD
Gemcitabine—POLD1—S Phase—CDKN1B—systemic lupus erythematosus	5.19e-05	0.00217	CbGpPWpGaD
Gemcitabine—Hyperhidrosis—Hydrocortisone—systemic lupus erythematosus	5.19e-05	0.000622	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Methotrexate—systemic lupus erythematosus	5.19e-05	0.000621	CcSEcCtD
Gemcitabine—Pain—Cyclosporine—systemic lupus erythematosus	5.16e-05	0.000619	CcSEcCtD
Gemcitabine—Constipation—Cyclosporine—systemic lupus erythematosus	5.16e-05	0.000619	CcSEcCtD
Gemcitabine—SLC28A3—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	5.16e-05	0.00216	CbGpPWpGaD
Gemcitabine—Renal failure—Methotrexate—systemic lupus erythematosus	5.14e-05	0.000616	CcSEcCtD
Gemcitabine—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	5.12e-05	0.000613	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	5.12e-05	0.00214	CbGpPWpGaD
Gemcitabine—Anorexia—Hydrocortisone—systemic lupus erythematosus	5.11e-05	0.000613	CcSEcCtD
Gemcitabine—Stomatitis—Methotrexate—systemic lupus erythematosus	5.1e-05	0.000611	CcSEcCtD
Gemcitabine—Angiopathy—Prednisone—systemic lupus erythematosus	5.1e-05	0.000611	CcSEcCtD
Gemcitabine—POLE—G1/S Transition—CDKN1A—systemic lupus erythematosus	5.1e-05	0.00213	CbGpPWpGaD
Gemcitabine—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	5.08e-05	0.000609	CcSEcCtD
Gemcitabine—Immune system disorder—Prednisone—systemic lupus erythematosus	5.08e-05	0.000608	CcSEcCtD
Gemcitabine—Malaise—Dexamethasone—systemic lupus erythematosus	5.06e-05	0.000607	CcSEcCtD
Gemcitabine—Malaise—Betamethasone—systemic lupus erythematosus	5.06e-05	0.000607	CcSEcCtD
Gemcitabine—Oedema—Triamcinolone—systemic lupus erythematosus	5.05e-05	0.000605	CcSEcCtD
Gemcitabine—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	5.05e-05	0.000605	CcSEcCtD
Gemcitabine—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	5.04e-05	0.000604	CcSEcCtD
Gemcitabine—Pain—Mycophenolate mofetil—systemic lupus erythematosus	5.04e-05	0.000604	CcSEcCtD
Gemcitabine—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	5.04e-05	0.000604	CcSEcCtD
Gemcitabine—Arrhythmia—Prednisone—systemic lupus erythematosus	5.02e-05	0.000602	CcSEcCtD
Gemcitabine—Infection—Triamcinolone—systemic lupus erythematosus	5.02e-05	0.000601	CcSEcCtD
Gemcitabine—Sweating—Methotrexate—systemic lupus erythematosus	5.01e-05	0.000601	CcSEcCtD
Gemcitabine—Hypotension—Hydrocortisone—systemic lupus erythematosus	5.01e-05	0.000601	CcSEcCtD
Gemcitabine—POLE—S Phase—CDKN1B—systemic lupus erythematosus	5.01e-05	0.0021	CbGpPWpGaD
Gemcitabine—Infection—Methylprednisolone—systemic lupus erythematosus	5.01e-05	0.0006	CcSEcCtD
Gemcitabine—POLA1—E2F transcription factor network—CDKN1A—systemic lupus erythematosus	5e-05	0.00209	CbGpPWpGaD
Gemcitabine—Haematuria—Methotrexate—systemic lupus erythematosus	4.99e-05	0.000598	CcSEcCtD
Gemcitabine—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	4.97e-05	0.000596	CcSEcCtD
Gemcitabine—Vomiting—Leflunomide—systemic lupus erythematosus	4.97e-05	0.000596	CcSEcCtD
Gemcitabine—Insomnia—Prednisolone—systemic lupus erythematosus	4.97e-05	0.000595	CcSEcCtD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	4.97e-05	0.00208	CbGpPWpGaD
Gemcitabine—Alopecia—Prednisone—systemic lupus erythematosus	4.97e-05	0.000595	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	4.95e-05	0.000593	CcSEcCtD
Gemcitabine—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	4.94e-05	0.000592	CcSEcCtD
Gemcitabine—Paraesthesia—Prednisolone—systemic lupus erythematosus	4.93e-05	0.000591	CcSEcCtD
Gemcitabine—Rash—Leflunomide—systemic lupus erythematosus	4.93e-05	0.000591	CcSEcCtD
Gemcitabine—Dermatitis—Leflunomide—systemic lupus erythematosus	4.93e-05	0.000591	CcSEcCtD
Gemcitabine—Nausea—Azathioprine—systemic lupus erythematosus	4.92e-05	0.00059	CcSEcCtD
Gemcitabine—Headache—Leflunomide—systemic lupus erythematosus	4.9e-05	0.000587	CcSEcCtD
Gemcitabine—Skin disorder—Methylprednisolone—systemic lupus erythematosus	4.9e-05	0.000587	CcSEcCtD
Gemcitabine—Erythema—Prednisone—systemic lupus erythematosus	4.89e-05	0.000586	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	4.89e-05	0.000586	CcSEcCtD
Gemcitabine—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	4.88e-05	0.000585	CcSEcCtD
Gemcitabine—Agranulocytosis—Methotrexate—systemic lupus erythematosus	4.88e-05	0.000585	CcSEcCtD
Gemcitabine—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	4.87e-05	0.000584	CcSEcCtD
Gemcitabine—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	4.85e-05	0.000582	CcSEcCtD
Gemcitabine—Insomnia—Hydrocortisone—systemic lupus erythematosus	4.85e-05	0.000582	CcSEcCtD
Gemcitabine—Hypertension—Dexamethasone—systemic lupus erythematosus	4.85e-05	0.000581	CcSEcCtD
Gemcitabine—Hypertension—Betamethasone—systemic lupus erythematosus	4.85e-05	0.000581	CcSEcCtD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—CDKN1B—systemic lupus erythematosus	4.85e-05	0.00203	CbGpPWpGaD
Gemcitabine—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	4.82e-05	0.000577	CcSEcCtD
Gemcitabine—TYMS—E2F transcription factor network—CDKN1A—systemic lupus erythematosus	4.79e-05	0.002	CbGpPWpGaD
Gemcitabine—POLD1—S Phase—CDKN1A—systemic lupus erythematosus	4.79e-05	0.002	CbGpPWpGaD
Gemcitabine—Myalgia—Betamethasone—systemic lupus erythematosus	4.78e-05	0.000573	CcSEcCtD
Gemcitabine—Myalgia—Dexamethasone—systemic lupus erythematosus	4.78e-05	0.000573	CcSEcCtD
Gemcitabine—Body temperature increased—Cyclosporine—systemic lupus erythematosus	4.77e-05	0.000572	CcSEcCtD
Gemcitabine—POLA1—E2F transcription factor network—EP300—systemic lupus erythematosus	4.76e-05	0.00199	CbGpPWpGaD
Gemcitabine—Discomfort—Dexamethasone—systemic lupus erythematosus	4.72e-05	0.000566	CcSEcCtD
Gemcitabine—Discomfort—Betamethasone—systemic lupus erythematosus	4.72e-05	0.000566	CcSEcCtD
Gemcitabine—Haemoglobin—Methotrexate—systemic lupus erythematosus	4.72e-05	0.000566	CcSEcCtD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—systemic lupus erythematosus	4.71e-05	0.00197	CbGpPWpGaD
Gemcitabine—Hypotension—Methylprednisolone—systemic lupus erythematosus	4.71e-05	0.000564	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	4.71e-05	0.00197	CbGpPWpGaD
Gemcitabine—Pain—Prednisolone—systemic lupus erythematosus	4.7e-05	0.000563	CcSEcCtD
Gemcitabine—Haemorrhage—Methotrexate—systemic lupus erythematosus	4.7e-05	0.000563	CcSEcCtD
Gemcitabine—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	4.66e-05	0.000559	CcSEcCtD
Gemcitabine—Pharyngitis—Methotrexate—systemic lupus erythematosus	4.66e-05	0.000559	CcSEcCtD
Gemcitabine—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	4.66e-05	0.000558	CcSEcCtD
Gemcitabine—POLE—Mitotic G1-G1/S phases—CDKN1B—systemic lupus erythematosus	4.65e-05	0.00194	CbGpPWpGaD
Gemcitabine—Nausea—Leflunomide—systemic lupus erythematosus	4.65e-05	0.000557	CcSEcCtD
Gemcitabine—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	4.64e-05	0.000556	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	4.63e-05	0.000555	CcSEcCtD
Gemcitabine—POLE—S Phase—CDKN1A—systemic lupus erythematosus	4.63e-05	0.00193	CbGpPWpGaD
Gemcitabine—Fatigue—Hydrocortisone—systemic lupus erythematosus	4.63e-05	0.000554	CcSEcCtD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	4.62e-05	0.00193	CbGpPWpGaD
Gemcitabine—Urethral disorder—Methotrexate—systemic lupus erythematosus	4.6e-05	0.000552	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	4.6e-05	0.000552	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	4.59e-05	0.00055	CcSEcCtD
Gemcitabine—Pain—Hydrocortisone—systemic lupus erythematosus	4.59e-05	0.00055	CcSEcCtD
Gemcitabine—Oedema—Dexamethasone—systemic lupus erythematosus	4.58e-05	0.000549	CcSEcCtD
Gemcitabine—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	4.58e-05	0.000549	CcSEcCtD
Gemcitabine—Oedema—Betamethasone—systemic lupus erythematosus	4.58e-05	0.000549	CcSEcCtD
Gemcitabine—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	4.58e-05	0.000549	CcSEcCtD
Gemcitabine—Insomnia—Triamcinolone—systemic lupus erythematosus	4.57e-05	0.000548	CcSEcCtD
Gemcitabine—TYMS—E2F transcription factor network—EP300—systemic lupus erythematosus	4.56e-05	0.00191	CbGpPWpGaD
Gemcitabine—Insomnia—Methylprednisolone—systemic lupus erythematosus	4.56e-05	0.000546	CcSEcCtD
Gemcitabine—Infection—Dexamethasone—systemic lupus erythematosus	4.55e-05	0.000546	CcSEcCtD
Gemcitabine—Infection—Betamethasone—systemic lupus erythematosus	4.55e-05	0.000546	CcSEcCtD
Gemcitabine—Ill-defined disorder—Prednisone—systemic lupus erythematosus	4.54e-05	0.000544	CcSEcCtD
Gemcitabine—Paraesthesia—Triamcinolone—systemic lupus erythematosus	4.54e-05	0.000544	CcSEcCtD
Gemcitabine—Feeling abnormal—Prednisolone—systemic lupus erythematosus	4.53e-05	0.000542	CcSEcCtD
Gemcitabine—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	4.53e-05	0.000542	CcSEcCtD
Gemcitabine—Anaemia—Prednisone—systemic lupus erythematosus	4.52e-05	0.000542	CcSEcCtD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—systemic lupus erythematosus	4.51e-05	0.00189	CbGpPWpGaD
Gemcitabine—DCK—Desoximetasone—Hydrocortisone—systemic lupus erythematosus	4.51e-05	0.0212	CbGdCrCtD
Gemcitabine—Dyspnoea—Triamcinolone—systemic lupus erythematosus	4.5e-05	0.00054	CcSEcCtD
Gemcitabine—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	4.5e-05	0.000539	CcSEcCtD
Gemcitabine—Nervous system disorder—Betamethasone—systemic lupus erythematosus	4.5e-05	0.000539	CcSEcCtD
Gemcitabine—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	4.49e-05	0.000538	CcSEcCtD
Gemcitabine—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	4.49e-05	0.000538	CcSEcCtD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—CDKN1A—systemic lupus erythematosus	4.47e-05	0.00187	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	4.46e-05	0.00186	CbGpPWpGaD
Gemcitabine—Erythema multiforme—Methotrexate—systemic lupus erythematosus	4.44e-05	0.000532	CcSEcCtD
Gemcitabine—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	4.43e-05	0.000531	CcSEcCtD
Gemcitabine—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	4.43e-05	0.000531	CcSEcCtD
Gemcitabine—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	4.42e-05	0.00053	CcSEcCtD
Gemcitabine—Malaise—Prednisone—systemic lupus erythematosus	4.41e-05	0.000529	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	4.37e-05	0.00183	CbGpPWpGaD
Gemcitabine—Anorexia—Betamethasone—systemic lupus erythematosus	4.37e-05	0.000524	CcSEcCtD
Gemcitabine—Anorexia—Dexamethasone—systemic lupus erythematosus	4.37e-05	0.000524	CcSEcCtD
Gemcitabine—Cardiac disorder—Methotrexate—systemic lupus erythematosus	4.36e-05	0.000522	CcSEcCtD
Gemcitabine—Fatigue—Triamcinolone—systemic lupus erythematosus	4.36e-05	0.000522	CcSEcCtD
Gemcitabine—POLA1—Synthesis of DNA—CDKN1B—systemic lupus erythematosus	4.35e-05	0.00182	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	4.35e-05	0.00182	CbGpPWpGaD
Gemcitabine—Fatigue—Methylprednisolone—systemic lupus erythematosus	4.35e-05	0.000521	CcSEcCtD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	4.34e-05	0.00181	CbGpPWpGaD
Gemcitabine—Asthenia—Cyclosporine—systemic lupus erythematosus	4.33e-05	0.000519	CcSEcCtD
Gemcitabine—Pain—Triamcinolone—systemic lupus erythematosus	4.32e-05	0.000518	CcSEcCtD
Gemcitabine—POLE—Mitotic G1-G1/S phases—CDKN1A—systemic lupus erythematosus	4.29e-05	0.00179	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—CXCL12—systemic lupus erythematosus	4.29e-05	0.00179	CbGpPWpGaD
Gemcitabine—Hypotension—Dexamethasone—systemic lupus erythematosus	4.28e-05	0.000513	CcSEcCtD
Gemcitabine—Hypotension—Betamethasone—systemic lupus erythematosus	4.28e-05	0.000513	CcSEcCtD
Gemcitabine—Pruritus—Cyclosporine—systemic lupus erythematosus	4.27e-05	0.000512	CcSEcCtD
Gemcitabine—Angiopathy—Methotrexate—systemic lupus erythematosus	4.26e-05	0.000511	CcSEcCtD
Gemcitabine—DCK—Desoximetasone—Methylprednisolone—systemic lupus erythematosus	4.26e-05	0.02	CbGdCrCtD
Gemcitabine—Immune system disorder—Methotrexate—systemic lupus erythematosus	4.24e-05	0.000508	CcSEcCtD
Gemcitabine—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	4.24e-05	0.000508	CcSEcCtD
Gemcitabine—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	4.23e-05	0.000507	CcSEcCtD
Gemcitabine—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	4.23e-05	0.000506	CcSEcCtD
Gemcitabine—Hypertension—Prednisone—systemic lupus erythematosus	4.22e-05	0.000506	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle, Mitotic—HIST2H2AC—systemic lupus erythematosus	4.22e-05	0.00176	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	4.22e-05	0.00176	CbGpPWpGaD
Gemcitabine—Chills—Methotrexate—systemic lupus erythematosus	4.21e-05	0.000505	CcSEcCtD
Gemcitabine—DCK—Desoximetasone—Dexamethasone—systemic lupus erythematosus	4.19e-05	0.0197	CbGdCrCtD
Gemcitabine—DCK—Desoximetasone—Betamethasone—systemic lupus erythematosus	4.19e-05	0.0197	CbGdCrCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	4.19e-05	0.00175	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	4.18e-05	0.0005	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	4.18e-05	0.0005	CcSEcCtD
Gemcitabine—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	4.17e-05	0.000499	CcSEcCtD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	4.17e-05	0.00174	CbGpPWpGaD
Gemcitabine—Myalgia—Prednisone—systemic lupus erythematosus	4.16e-05	0.000499	CcSEcCtD
Gemcitabine—Arthralgia—Prednisone—systemic lupus erythematosus	4.16e-05	0.000499	CcSEcCtD
Gemcitabine—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	4.16e-05	0.000499	CcSEcCtD
Gemcitabine—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	4.15e-05	0.000498	CcSEcCtD
Gemcitabine—Alopecia—Methotrexate—systemic lupus erythematosus	4.15e-05	0.000497	CcSEcCtD
Gemcitabine—CDA—Metabolism—NAT2—systemic lupus erythematosus	4.15e-05	0.00173	CbGpPWpGaD
Gemcitabine—Insomnia—Dexamethasone—systemic lupus erythematosus	4.15e-05	0.000497	CcSEcCtD
Gemcitabine—Insomnia—Betamethasone—systemic lupus erythematosus	4.15e-05	0.000497	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—IL17A—systemic lupus erythematosus	4.15e-05	0.00173	CbGpPWpGaD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	4.14e-05	0.000496	CcSEcCtD
Gemcitabine—DCK—Diflorasone—Methylprednisolone—systemic lupus erythematosus	4.13e-05	0.0194	CbGdCrCtD
Gemcitabine—Diarrhoea—Cyclosporine—systemic lupus erythematosus	4.13e-05	0.000495	CcSEcCtD
Gemcitabine—Paraesthesia—Betamethasone—systemic lupus erythematosus	4.12e-05	0.000493	CcSEcCtD
Gemcitabine—Paraesthesia—Dexamethasone—systemic lupus erythematosus	4.12e-05	0.000493	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	4.12e-05	0.00172	CbGpPWpGaD
Gemcitabine—Discomfort—Prednisone—systemic lupus erythematosus	4.11e-05	0.000493	CcSEcCtD
Gemcitabine—DCK—Desoximetasone—Triamcinolone—systemic lupus erythematosus	4.09e-05	0.0192	CbGdCrCtD
Gemcitabine—Erythema—Methotrexate—systemic lupus erythematosus	4.09e-05	0.00049	CcSEcCtD
Gemcitabine—POLA1—DNA Replication—CDKN1B—systemic lupus erythematosus	4.08e-05	0.00171	CbGpPWpGaD
Gemcitabine—DCK—Diflorasone—Betamethasone—systemic lupus erythematosus	4.07e-05	0.0191	CbGdCrCtD
Gemcitabine—DCK—Diflorasone—Dexamethasone—systemic lupus erythematosus	4.07e-05	0.0191	CbGdCrCtD
Gemcitabine—TYMS—Cell Cycle, Mitotic—HIST2H2AC—systemic lupus erythematosus	4.04e-05	0.00169	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	4.04e-05	0.00169	CbGpPWpGaD
Gemcitabine—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	4.03e-05	0.000483	CcSEcCtD
Gemcitabine—POLA1—Synthesis of DNA—CDKN1A—systemic lupus erythematosus	4.02e-05	0.00168	CbGpPWpGaD
Gemcitabine—Body temperature increased—Triamcinolone—systemic lupus erythematosus	3.99e-05	0.000479	CcSEcCtD
Gemcitabine—Oedema—Prednisone—systemic lupus erythematosus	3.99e-05	0.000478	CcSEcCtD
Gemcitabine—Anaphylactic shock—Prednisone—systemic lupus erythematosus	3.99e-05	0.000478	CcSEcCtD
Gemcitabine—Decreased appetite—Betamethasone—systemic lupus erythematosus	3.98e-05	0.000478	CcSEcCtD
Gemcitabine—Decreased appetite—Dexamethasone—systemic lupus erythematosus	3.98e-05	0.000478	CcSEcCtD
Gemcitabine—DCK—Diflorasone—Triamcinolone—systemic lupus erythematosus	3.97e-05	0.0187	CbGdCrCtD
Gemcitabine—Infection—Prednisone—systemic lupus erythematosus	3.97e-05	0.000475	CcSEcCtD
Gemcitabine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	3.96e-05	0.00166	CbGpPWpGaD
Gemcitabine—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	3.96e-05	0.000474	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	3.96e-05	0.000474	CcSEcCtD
Gemcitabine—Back pain—Methotrexate—systemic lupus erythematosus	3.95e-05	0.000474	CcSEcCtD
Gemcitabine—Fatigue—Dexamethasone—systemic lupus erythematosus	3.95e-05	0.000474	CcSEcCtD
Gemcitabine—Fatigue—Betamethasone—systemic lupus erythematosus	3.95e-05	0.000474	CcSEcCtD
Gemcitabine—POLA1—G1/S Transition—CDKN1B—systemic lupus erythematosus	3.93e-05	0.00164	CbGpPWpGaD
Gemcitabine—Pain—Betamethasone—systemic lupus erythematosus	3.92e-05	0.00047	CcSEcCtD
Gemcitabine—Pain—Dexamethasone—systemic lupus erythematosus	3.92e-05	0.00047	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	3.92e-05	0.00164	CbGpPWpGaD
Gemcitabine—Nervous system disorder—Prednisone—systemic lupus erythematosus	3.91e-05	0.000469	CcSEcCtD
Gemcitabine—DCK—Desoximetasone—Prednisone—systemic lupus erythematosus	3.89e-05	0.0182	CbGdCrCtD
Gemcitabine—TYMS—Circadian rythm related genes—FAS—systemic lupus erythematosus	3.88e-05	0.00162	CbGpPWpGaD
Gemcitabine—Skin disorder—Prednisone—systemic lupus erythematosus	3.88e-05	0.000465	CcSEcCtD
Gemcitabine—Hyperhidrosis—Prednisone—systemic lupus erythematosus	3.86e-05	0.000462	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—IL12B—systemic lupus erythematosus	3.85e-05	0.00161	CbGpPWpGaD
Gemcitabine—Asthenia—Hydrocortisone—systemic lupus erythematosus	3.85e-05	0.000461	CcSEcCtD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	3.85e-05	0.00161	CbGpPWpGaD
Gemcitabine—Vomiting—Cyclosporine—systemic lupus erythematosus	3.84e-05	0.00046	CcSEcCtD
Gemcitabine—Rash—Cyclosporine—systemic lupus erythematosus	3.81e-05	0.000456	CcSEcCtD
Gemcitabine—Anorexia—Prednisone—systemic lupus erythematosus	3.81e-05	0.000456	CcSEcCtD
Gemcitabine—Dermatitis—Cyclosporine—systemic lupus erythematosus	3.8e-05	0.000456	CcSEcCtD
Gemcitabine—Pruritus—Hydrocortisone—systemic lupus erythematosus	3.8e-05	0.000455	CcSEcCtD
Gemcitabine—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	3.79e-05	0.000455	CcSEcCtD
Gemcitabine—DCK—Desoximetasone—Prednisolone—systemic lupus erythematosus	3.79e-05	0.0178	CbGdCrCtD
Gemcitabine—Headache—Cyclosporine—systemic lupus erythematosus	3.78e-05	0.000453	CcSEcCtD
Gemcitabine—Anaemia—Methotrexate—systemic lupus erythematosus	3.78e-05	0.000453	CcSEcCtD
Gemcitabine—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	3.78e-05	0.000453	CcSEcCtD
Gemcitabine—Feeling abnormal—Betamethasone—systemic lupus erythematosus	3.78e-05	0.000453	CcSEcCtD
Gemcitabine—DCK—Diflorasone—Prednisone—systemic lupus erythematosus	3.77e-05	0.0177	CbGdCrCtD
Gemcitabine—POLA1—Cell Cycle—HIST2H2AC—systemic lupus erythematosus	3.77e-05	0.00158	CbGpPWpGaD
Gemcitabine—POLA1—DNA Replication—CDKN1A—systemic lupus erythematosus	3.77e-05	0.00158	CbGpPWpGaD
Gemcitabine—TYMS—G1/S Transition—CDKN1B—systemic lupus erythematosus	3.77e-05	0.00158	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—RXRA—systemic lupus erythematosus	3.77e-05	0.00157	CbGpPWpGaD
Gemcitabine—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	3.74e-05	0.000449	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—CXCL12—systemic lupus erythematosus	3.72e-05	0.00155	CbGpPWpGaD
Gemcitabine—Rash—Mycophenolate mofetil—systemic lupus erythematosus	3.71e-05	0.000445	CcSEcCtD
Gemcitabine—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	3.71e-05	0.000445	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	3.71e-05	0.00155	CbGpPWpGaD
Gemcitabine—Headache—Mycophenolate mofetil—systemic lupus erythematosus	3.69e-05	0.000442	CcSEcCtD
Gemcitabine—Malaise—Methotrexate—systemic lupus erythematosus	3.69e-05	0.000442	CcSEcCtD
Gemcitabine—DCK—Diflorasone—Prednisolone—systemic lupus erythematosus	3.68e-05	0.0173	CbGdCrCtD
Gemcitabine—ABCB1—Allograft Rejection—CD40—systemic lupus erythematosus	3.68e-05	0.00154	CbGpPWpGaD
Gemcitabine—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	3.67e-05	0.00044	CcSEcCtD
Gemcitabine—Leukopenia—Methotrexate—systemic lupus erythematosus	3.66e-05	0.000438	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	3.64e-05	0.000436	CcSEcCtD
Gemcitabine—POLA1—G1/S Transition—CDKN1A—systemic lupus erythematosus	3.63e-05	0.00152	CbGpPWpGaD
Gemcitabine—Asthenia—Triamcinolone—systemic lupus erythematosus	3.62e-05	0.000434	CcSEcCtD
Gemcitabine—Body temperature increased—Betamethasone—systemic lupus erythematosus	3.62e-05	0.000434	CcSEcCtD
Gemcitabine—Body temperature increased—Dexamethasone—systemic lupus erythematosus	3.62e-05	0.000434	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—CTLA4—systemic lupus erythematosus	3.62e-05	0.00151	CbGpPWpGaD
Gemcitabine—Asthenia—Methylprednisolone—systemic lupus erythematosus	3.62e-05	0.000433	CcSEcCtD
Gemcitabine—TYMS—Flunisolide—Hydrocortisone—systemic lupus erythematosus	3.61e-05	0.017	CbGdCrCtD
Gemcitabine—TYMS—Cell Cycle—HIST2H2AC—systemic lupus erythematosus	3.61e-05	0.00151	CbGpPWpGaD
Gemcitabine—Insomnia—Prednisone—systemic lupus erythematosus	3.61e-05	0.000433	CcSEcCtD
Gemcitabine—Nausea—Cyclosporine—systemic lupus erythematosus	3.59e-05	0.00043	CcSEcCtD
Gemcitabine—Paraesthesia—Prednisone—systemic lupus erythematosus	3.58e-05	0.00043	CcSEcCtD
Gemcitabine—TYMS—Triamcinolone—Hydrocortisone—systemic lupus erythematosus	3.58e-05	0.0168	CbGdCrCtD
Gemcitabine—Pruritus—Triamcinolone—systemic lupus erythematosus	3.57e-05	0.000428	CcSEcCtD
Gemcitabine—POLA1—S Phase—CDKN1B—systemic lupus erythematosus	3.57e-05	0.00149	CbGpPWpGaD
Gemcitabine—Cough—Methotrexate—systemic lupus erythematosus	3.57e-05	0.000427	CcSEcCtD
Gemcitabine—Pruritus—Methylprednisolone—systemic lupus erythematosus	3.57e-05	0.000427	CcSEcCtD
Gemcitabine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	3.5e-05	0.000419	CcSEcCtD
Gemcitabine—Chest pain—Methotrexate—systemic lupus erythematosus	3.48e-05	0.000417	CcSEcCtD
Gemcitabine—Myalgia—Methotrexate—systemic lupus erythematosus	3.48e-05	0.000417	CcSEcCtD
Gemcitabine—Arthralgia—Methotrexate—systemic lupus erythematosus	3.48e-05	0.000417	CcSEcCtD
Gemcitabine—TYMS—G1/S Transition—CDKN1A—systemic lupus erythematosus	3.48e-05	0.00145	CbGpPWpGaD
Gemcitabine—Decreased appetite—Prednisone—systemic lupus erythematosus	3.47e-05	0.000416	CcSEcCtD
Gemcitabine—Rash—Prednisolone—systemic lupus erythematosus	3.46e-05	0.000415	CcSEcCtD
Gemcitabine—Dermatitis—Prednisolone—systemic lupus erythematosus	3.46e-05	0.000415	CcSEcCtD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.46e-05	0.00145	CbGpPWpGaD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	3.46e-05	0.000414	CcSEcCtD
Gemcitabine—TYMS—Clobetasol propionate—Methylprednisolone—systemic lupus erythematosus	3.46e-05	0.0162	CbGdCrCtD
Gemcitabine—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	3.45e-05	0.000413	CcSEcCtD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	3.44e-05	0.00144	CbGpPWpGaD
Gemcitabine—Fatigue—Prednisone—systemic lupus erythematosus	3.44e-05	0.000412	CcSEcCtD
Gemcitabine—Headache—Prednisolone—systemic lupus erythematosus	3.44e-05	0.000412	CcSEcCtD
Gemcitabine—Discomfort—Methotrexate—systemic lupus erythematosus	3.44e-05	0.000412	CcSEcCtD
Gemcitabine—Constipation—Prednisone—systemic lupus erythematosus	3.41e-05	0.000409	CcSEcCtD
Gemcitabine—Vomiting—Hydrocortisone—systemic lupus erythematosus	3.41e-05	0.000409	CcSEcCtD
Gemcitabine—TYMS—Flunisolide—Methylprednisolone—systemic lupus erythematosus	3.41e-05	0.016	CbGdCrCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	3.4e-05	0.00142	CbGpPWpGaD
Gemcitabine—TYMS—Clobetasol propionate—Dexamethasone—systemic lupus erythematosus	3.4e-05	0.016	CbGdCrCtD
Gemcitabine—TYMS—Clobetasol propionate—Betamethasone—systemic lupus erythematosus	3.4e-05	0.016	CbGdCrCtD
Gemcitabine—Rash—Hydrocortisone—systemic lupus erythematosus	3.38e-05	0.000405	CcSEcCtD
Gemcitabine—Dermatitis—Hydrocortisone—systemic lupus erythematosus	3.38e-05	0.000405	CcSEcCtD
Gemcitabine—TYMS—Triamcinolone—Methylprednisolone—systemic lupus erythematosus	3.38e-05	0.0158	CbGdCrCtD
Gemcitabine—Headache—Hydrocortisone—systemic lupus erythematosus	3.36e-05	0.000403	CcSEcCtD
Gemcitabine—TYMS—Flunisolide—Betamethasone—systemic lupus erythematosus	3.36e-05	0.0158	CbGdCrCtD
Gemcitabine—TYMS—Flunisolide—Dexamethasone—systemic lupus erythematosus	3.36e-05	0.0158	CbGdCrCtD
Gemcitabine—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	3.34e-05	0.0004	CcSEcCtD
Gemcitabine—TYMS—Clobetasol propionate—Triamcinolone—systemic lupus erythematosus	3.32e-05	0.0156	CbGdCrCtD
Gemcitabine—TYMS—Triamcinolone—Dexamethasone—systemic lupus erythematosus	3.32e-05	0.0156	CbGdCrCtD
Gemcitabine—TYMS—Triamcinolone—Betamethasone—systemic lupus erythematosus	3.32e-05	0.0156	CbGdCrCtD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—systemic lupus erythematosus	3.32e-05	0.00139	CbGpPWpGaD
Gemcitabine—Infection—Methotrexate—systemic lupus erythematosus	3.31e-05	0.000397	CcSEcCtD
Gemcitabine—POLA1—S Phase—CDKN1A—systemic lupus erythematosus	3.3e-05	0.00138	CbGpPWpGaD
Gemcitabine—TYMS—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	3.29e-05	0.0155	CbGdCrCtD
Gemcitabine—Feeling abnormal—Prednisone—systemic lupus erythematosus	3.29e-05	0.000394	CcSEcCtD
Gemcitabine—Asthenia—Betamethasone—systemic lupus erythematosus	3.29e-05	0.000394	CcSEcCtD
Gemcitabine—Asthenia—Dexamethasone—systemic lupus erythematosus	3.29e-05	0.000394	CcSEcCtD
Gemcitabine—TYMS—Flunisolide—Triamcinolone—systemic lupus erythematosus	3.28e-05	0.0154	CbGdCrCtD
Gemcitabine—Nervous system disorder—Methotrexate—systemic lupus erythematosus	3.27e-05	0.000392	CcSEcCtD
Gemcitabine—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	3.27e-05	0.000391	CcSEcCtD
Gemcitabine—Nausea—Prednisolone—systemic lupus erythematosus	3.26e-05	0.000391	CcSEcCtD
Gemcitabine—Pruritus—Dexamethasone—systemic lupus erythematosus	3.24e-05	0.000389	CcSEcCtD
Gemcitabine—Pruritus—Betamethasone—systemic lupus erythematosus	3.24e-05	0.000389	CcSEcCtD
Gemcitabine—Skin disorder—Methotrexate—systemic lupus erythematosus	3.24e-05	0.000388	CcSEcCtD
Gemcitabine—TYMS—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	3.24e-05	0.0152	CbGdCrCtD
Gemcitabine—TYMS—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	3.24e-05	0.0152	CbGdCrCtD
Gemcitabine—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	3.23e-05	0.000386	CcSEcCtD
Gemcitabine—Vomiting—Triamcinolone—systemic lupus erythematosus	3.21e-05	0.000385	CcSEcCtD
Gemcitabine—Vomiting—Methylprednisolone—systemic lupus erythematosus	3.2e-05	0.000384	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—HLA-DQA1—systemic lupus erythematosus	3.19e-05	0.00133	CbGpPWpGaD
Gemcitabine—Nausea—Hydrocortisone—systemic lupus erythematosus	3.19e-05	0.000382	CcSEcCtD
Gemcitabine—Rash—Triamcinolone—systemic lupus erythematosus	3.19e-05	0.000382	CcSEcCtD
Gemcitabine—Dermatitis—Triamcinolone—systemic lupus erythematosus	3.18e-05	0.000381	CcSEcCtD
Gemcitabine—Anorexia—Methotrexate—systemic lupus erythematosus	3.18e-05	0.000381	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	3.18e-05	0.00133	CbGpPWpGaD
Gemcitabine—Rash—Methylprednisolone—systemic lupus erythematosus	3.18e-05	0.000381	CcSEcCtD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CDKN1B—systemic lupus erythematosus	3.18e-05	0.00133	CbGpPWpGaD
Gemcitabine—Dermatitis—Methylprednisolone—systemic lupus erythematosus	3.18e-05	0.000381	CcSEcCtD
Gemcitabine—TYMS—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	3.17e-05	0.0149	CbGdCrCtD
Gemcitabine—Headache—Triamcinolone—systemic lupus erythematosus	3.16e-05	0.000379	CcSEcCtD
Gemcitabine—Headache—Methylprednisolone—systemic lupus erythematosus	3.16e-05	0.000378	CcSEcCtD
Gemcitabine—Body temperature increased—Prednisone—systemic lupus erythematosus	3.16e-05	0.000378	CcSEcCtD
Gemcitabine—TYMS—Clobetasol propionate—Prednisone—systemic lupus erythematosus	3.15e-05	0.0148	CbGdCrCtD
Gemcitabine—RRM1—Metabolism—NAT2—systemic lupus erythematosus	3.14e-05	0.00131	CbGpPWpGaD
Gemcitabine—Diarrhoea—Betamethasone—systemic lupus erythematosus	3.14e-05	0.000376	CcSEcCtD
Gemcitabine—Diarrhoea—Dexamethasone—systemic lupus erythematosus	3.14e-05	0.000376	CcSEcCtD
Gemcitabine—Hypotension—Methotrexate—systemic lupus erythematosus	3.12e-05	0.000374	CcSEcCtD
Gemcitabine—TYMS—Flunisolide—Prednisone—systemic lupus erythematosus	3.11e-05	0.0146	CbGdCrCtD
Gemcitabine—TYMS—Diflorasone—Methylprednisolone—systemic lupus erythematosus	3.11e-05	0.0146	CbGdCrCtD
Gemcitabine—TYMS—Circadian rythm related genes—PPARG—systemic lupus erythematosus	3.1e-05	0.0013	CbGpPWpGaD
Gemcitabine—TYMS—Triamcinolone—Prednisone—systemic lupus erythematosus	3.08e-05	0.0145	CbGdCrCtD
Gemcitabine—TYMS—Clobetasol propionate—Prednisolone—systemic lupus erythematosus	3.08e-05	0.0145	CbGdCrCtD
Gemcitabine—TYMS—Diflorasone—Betamethasone—systemic lupus erythematosus	3.06e-05	0.0144	CbGdCrCtD
Gemcitabine—TYMS—Diflorasone—Dexamethasone—systemic lupus erythematosus	3.06e-05	0.0144	CbGdCrCtD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—systemic lupus erythematosus	3.06e-05	0.00128	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	3.04e-05	0.000364	CcSEcCtD
Gemcitabine—TYMS—Flunisolide—Prednisolone—systemic lupus erythematosus	3.04e-05	0.0143	CbGdCrCtD
Gemcitabine—Insomnia—Methotrexate—systemic lupus erythematosus	3.02e-05	0.000362	CcSEcCtD
Gemcitabine—TYMS—Triamcinolone—Prednisolone—systemic lupus erythematosus	3.01e-05	0.0141	CbGdCrCtD
Gemcitabine—Nausea—Triamcinolone—systemic lupus erythematosus	3e-05	0.00036	CcSEcCtD
Gemcitabine—Paraesthesia—Methotrexate—systemic lupus erythematosus	3e-05	0.000359	CcSEcCtD
Gemcitabine—Nausea—Methylprednisolone—systemic lupus erythematosus	2.99e-05	0.000359	CcSEcCtD
Gemcitabine—TYMS—Diflorasone—Triamcinolone—systemic lupus erythematosus	2.99e-05	0.014	CbGdCrCtD
Gemcitabine—ABCB1—Allograft Rejection—HLA-DQB1—systemic lupus erythematosus	2.98e-05	0.00125	CbGpPWpGaD
Gemcitabine—Dyspnoea—Methotrexate—systemic lupus erythematosus	2.97e-05	0.000356	CcSEcCtD
Gemcitabine—Somnolence—Methotrexate—systemic lupus erythematosus	2.97e-05	0.000355	CcSEcCtD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CDKN1A—systemic lupus erythematosus	2.93e-05	0.00123	CbGpPWpGaD
Gemcitabine—Vomiting—Betamethasone—systemic lupus erythematosus	2.91e-05	0.000349	CcSEcCtD
Gemcitabine—Vomiting—Dexamethasone—systemic lupus erythematosus	2.91e-05	0.000349	CcSEcCtD
Gemcitabine—Decreased appetite—Methotrexate—systemic lupus erythematosus	2.9e-05	0.000348	CcSEcCtD
Gemcitabine—TYMS—Budesonide—Hydrocortisone—systemic lupus erythematosus	2.89e-05	0.0136	CbGdCrCtD
Gemcitabine—Rash—Dexamethasone—systemic lupus erythematosus	2.89e-05	0.000346	CcSEcCtD
Gemcitabine—Rash—Betamethasone—systemic lupus erythematosus	2.89e-05	0.000346	CcSEcCtD
Gemcitabine—Dermatitis—Dexamethasone—systemic lupus erythematosus	2.89e-05	0.000346	CcSEcCtD
Gemcitabine—Dermatitis—Betamethasone—systemic lupus erythematosus	2.89e-05	0.000346	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	2.88e-05	0.000345	CcSEcCtD
Gemcitabine—Fatigue—Methotrexate—systemic lupus erythematosus	2.88e-05	0.000345	CcSEcCtD
Gemcitabine—Headache—Betamethasone—systemic lupus erythematosus	2.87e-05	0.000344	CcSEcCtD
Gemcitabine—Headache—Dexamethasone—systemic lupus erythematosus	2.87e-05	0.000344	CcSEcCtD
Gemcitabine—Asthenia—Prednisone—systemic lupus erythematosus	2.86e-05	0.000343	CcSEcCtD
Gemcitabine—Pain—Methotrexate—systemic lupus erythematosus	2.85e-05	0.000342	CcSEcCtD
Gemcitabine—TYMS—Diflorasone—Prednisone—systemic lupus erythematosus	2.84e-05	0.0133	CbGdCrCtD
Gemcitabine—Pruritus—Prednisone—systemic lupus erythematosus	2.82e-05	0.000338	CcSEcCtD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.82e-05	0.00118	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL10—systemic lupus erythematosus	2.82e-05	0.00118	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CD40LG—systemic lupus erythematosus	2.82e-05	0.00118	CbGpPWpGaD
Gemcitabine—TYMS—Diflorasone—Prednisolone—systemic lupus erythematosus	2.77e-05	0.013	CbGdCrCtD
Gemcitabine—TYMS—Danazol—Hydrocortisone—systemic lupus erythematosus	2.77e-05	0.013	CbGdCrCtD
Gemcitabine—Feeling abnormal—Methotrexate—systemic lupus erythematosus	2.75e-05	0.000329	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—IL4—systemic lupus erythematosus	2.74e-05	0.00115	CbGpPWpGaD
Gemcitabine—Diarrhoea—Prednisone—systemic lupus erythematosus	2.73e-05	0.000327	CcSEcCtD
Gemcitabine—TYMS—Budesonide—Methylprednisolone—systemic lupus erythematosus	2.73e-05	0.0128	CbGdCrCtD
Gemcitabine—Nausea—Betamethasone—systemic lupus erythematosus	2.72e-05	0.000326	CcSEcCtD
Gemcitabine—Nausea—Dexamethasone—systemic lupus erythematosus	2.72e-05	0.000326	CcSEcCtD
Gemcitabine—TYMS—Budesonide—Dexamethasone—systemic lupus erythematosus	2.68e-05	0.0126	CbGdCrCtD
Gemcitabine—TYMS—Budesonide—Betamethasone—systemic lupus erythematosus	2.68e-05	0.0126	CbGdCrCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	2.65e-05	0.00111	CbGpPWpGaD
Gemcitabine—DCK—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	2.64e-05	0.0124	CbGdCrCtD
Gemcitabine—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.64e-05	0.000316	CcSEcCtD
Gemcitabine—TYMS—Budesonide—Triamcinolone—systemic lupus erythematosus	2.62e-05	0.0123	CbGdCrCtD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.62e-05	0.0011	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—FASLG—systemic lupus erythematosus	2.62e-05	0.00109	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—NAT2—systemic lupus erythematosus	2.59e-05	0.00108	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—NAT2—systemic lupus erythematosus	2.57e-05	0.00108	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	2.54e-05	0.00106	CbGpPWpGaD
Gemcitabine—Vomiting—Prednisone—systemic lupus erythematosus	2.54e-05	0.000304	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—FAS—systemic lupus erythematosus	2.53e-05	0.00106	CbGpPWpGaD
Gemcitabine—Rash—Prednisone—systemic lupus erythematosus	2.52e-05	0.000302	CcSEcCtD
Gemcitabine—Dermatitis—Prednisone—systemic lupus erythematosus	2.51e-05	0.000301	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	2.51e-05	0.00105	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL2RA—systemic lupus erythematosus	2.51e-05	0.00105	CbGpPWpGaD
Gemcitabine—Headache—Prednisone—systemic lupus erythematosus	2.5e-05	0.0003	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—C3—systemic lupus erythematosus	2.49e-05	0.00104	CbGpPWpGaD
Gemcitabine—TYMS—Budesonide—Prednisone—systemic lupus erythematosus	2.49e-05	0.0117	CbGdCrCtD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.46e-05	0.00103	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	2.46e-05	0.00103	CbGpPWpGaD
Gemcitabine—TYMS—Budesonide—Prednisolone—systemic lupus erythematosus	2.43e-05	0.0114	CbGdCrCtD
Gemcitabine—DCK—Metabolism—NAT2—systemic lupus erythematosus	2.42e-05	0.00101	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	2.41e-05	0.00101	CbGpPWpGaD
Gemcitabine—Asthenia—Methotrexate—systemic lupus erythematosus	2.39e-05	0.000287	CcSEcCtD
Gemcitabine—TYMS—Danazol—Prednisone—systemic lupus erythematosus	2.39e-05	0.0112	CbGdCrCtD
Gemcitabine—CMPK1—Metabolism—PPARG—systemic lupus erythematosus	2.38e-05	0.000994	CbGpPWpGaD
Gemcitabine—Nausea—Prednisone—systemic lupus erythematosus	2.37e-05	0.000284	CcSEcCtD
Gemcitabine—Pruritus—Methotrexate—systemic lupus erythematosus	2.36e-05	0.000283	CcSEcCtD
Gemcitabine—CDA—Metabolism—RXRA—systemic lupus erythematosus	2.33e-05	0.000972	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	2.32e-05	0.000969	CbGpPWpGaD
Gemcitabine—Diarrhoea—Methotrexate—systemic lupus erythematosus	2.28e-05	0.000274	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	2.27e-05	0.000948	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	2.22e-05	0.000928	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	2.21e-05	0.000922	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	2.2e-05	0.000921	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—ALB—systemic lupus erythematosus	2.14e-05	0.000893	CbGpPWpGaD
Gemcitabine—Vomiting—Methotrexate—systemic lupus erythematosus	2.12e-05	0.000254	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	2.11e-05	0.000883	CbGpPWpGaD
Gemcitabine—Rash—Methotrexate—systemic lupus erythematosus	2.1e-05	0.000252	CcSEcCtD
Gemcitabine—Dermatitis—Methotrexate—systemic lupus erythematosus	2.1e-05	0.000252	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—CD80—systemic lupus erythematosus	2.1e-05	0.000876	CbGpPWpGaD
Gemcitabine—Headache—Methotrexate—systemic lupus erythematosus	2.09e-05	0.00025	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	2.09e-05	0.000873	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—NOS3—systemic lupus erythematosus	2.04e-05	0.000855	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—EP300—systemic lupus erythematosus	2.03e-05	0.000848	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	2e-05	0.000836	CbGpPWpGaD
Gemcitabine—TYMS—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	1.99e-05	0.00932	CbGdCrCtD
Gemcitabine—Nausea—Methotrexate—systemic lupus erythematosus	1.98e-05	0.000237	CcSEcCtD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.95e-05	0.000817	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.92e-05	0.000801	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	1.91e-05	0.000798	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTGS2—systemic lupus erythematosus	1.87e-05	0.000782	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.84e-05	0.000768	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	1.8e-05	0.000753	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.79e-05	0.000748	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	1.78e-05	0.000743	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	1.77e-05	0.000738	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—RXRA—systemic lupus erythematosus	1.76e-05	0.000737	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.72e-05	0.000717	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	1.71e-05	0.000713	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—NAT2—systemic lupus erythematosus	1.7e-05	0.000709	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IFNG—systemic lupus erythematosus	1.66e-05	0.000693	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	1.64e-05	0.000686	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	1.63e-05	0.000682	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN1B—systemic lupus erythematosus	1.59e-05	0.000664	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN1B—systemic lupus erythematosus	1.58e-05	0.00066	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	1.58e-05	0.00066	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	1.57e-05	0.000658	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	1.56e-05	0.000652	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—EP300—systemic lupus erythematosus	1.56e-05	0.00065	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	1.55e-05	0.000648	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN1B—systemic lupus erythematosus	1.53e-05	0.000638	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	1.53e-05	0.000638	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	1.5e-05	0.000626	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL2—systemic lupus erythematosus	1.47e-05	0.000615	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PPARG—systemic lupus erythematosus	1.47e-05	0.000614	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN1A—systemic lupus erythematosus	1.47e-05	0.000613	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN1A—systemic lupus erythematosus	1.46e-05	0.000609	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—RXRA—systemic lupus erythematosus	1.45e-05	0.000607	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	1.44e-05	0.000604	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—RXRA—systemic lupus erythematosus	1.44e-05	0.000603	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN1A—systemic lupus erythematosus	1.41e-05	0.000589	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—EP300—systemic lupus erythematosus	1.4e-05	0.000583	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—EP300—systemic lupus erythematosus	1.39e-05	0.00058	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—RXRA—systemic lupus erythematosus	1.36e-05	0.000567	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—EP300—systemic lupus erythematosus	1.34e-05	0.00056	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—IL6—systemic lupus erythematosus	1.33e-05	0.000555	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ALB—systemic lupus erythematosus	1.32e-05	0.000552	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	1.29e-05	0.00054	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—NOS3—systemic lupus erythematosus	1.26e-05	0.000528	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—VEGFA—systemic lupus erythematosus	1.25e-05	0.000523	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	1.25e-05	0.000521	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	1.22e-05	0.000508	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	1.16e-05	0.000487	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTGS2—systemic lupus erythematosus	1.16e-05	0.000483	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	1.15e-05	0.00048	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	1.12e-05	0.000469	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PPARG—systemic lupus erythematosus	1.11e-05	0.000465	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN1B—systemic lupus erythematosus	1.09e-05	0.000454	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	1.08e-05	0.000449	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	1.07e-05	0.000448	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	1.07e-05	0.000446	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN1B—systemic lupus erythematosus	1.04e-05	0.000435	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	1.02e-05	0.000428	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN1A—systemic lupus erythematosus	1e-05	0.000419	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ALB—systemic lupus erythematosus	1e-05	0.000418	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN1A—systemic lupus erythematosus	9.61e-06	0.000402	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—EP300—systemic lupus erythematosus	9.61e-06	0.000402	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—NOS3—systemic lupus erythematosus	9.57e-06	0.0004	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—EP300—systemic lupus erythematosus	9.55e-06	0.000399	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—RXRA—systemic lupus erythematosus	9.51e-06	0.000398	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PPARG—systemic lupus erythematosus	9.17e-06	0.000383	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—EP300—systemic lupus erythematosus	9.15e-06	0.000382	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PPARG—systemic lupus erythematosus	9.11e-06	0.000381	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTGS2—systemic lupus erythematosus	8.76e-06	0.000366	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PPARG—systemic lupus erythematosus	8.57e-06	0.000358	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ALB—systemic lupus erythematosus	8.24e-06	0.000344	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ALB—systemic lupus erythematosus	8.19e-06	0.000342	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—NOS3—systemic lupus erythematosus	7.88e-06	0.000329	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	7.84e-06	0.000328	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—NOS3—systemic lupus erythematosus	7.84e-06	0.000327	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ALB—systemic lupus erythematosus	7.7e-06	0.000322	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	7.42e-06	0.00031	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—NOS3—systemic lupus erythematosus	7.37e-06	0.000308	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—EP300—systemic lupus erythematosus	7.28e-06	0.000304	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTGS2—systemic lupus erythematosus	7.21e-06	0.000301	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTGS2—systemic lupus erythematosus	7.17e-06	0.0003	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	6.85e-06	0.000286	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTGS2—systemic lupus erythematosus	6.74e-06	0.000282	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	6.52e-06	0.000272	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	6.27e-06	0.000262	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	6.18e-06	0.000258	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PPARG—systemic lupus erythematosus	6.01e-06	0.000251	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—EP300—systemic lupus erythematosus	6e-06	0.000251	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—EP300—systemic lupus erythematosus	5.96e-06	0.000249	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	5.67e-06	0.000237	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—EP300—systemic lupus erythematosus	5.6e-06	0.000234	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ALB—systemic lupus erythematosus	5.4e-06	0.000226	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	5.29e-06	0.000221	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	5.24e-06	0.000219	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—NOS3—systemic lupus erythematosus	5.17e-06	0.000216	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTGS2—systemic lupus erythematosus	4.72e-06	0.000197	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—EP300—systemic lupus erythematosus	3.93e-06	0.000164	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.56e-06	0.000149	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	2.94e-06	0.000123	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	1.85e-06	7.75e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ALB—systemic lupus erythematosus	1.67e-06	6.96e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	1.59e-06	6.66e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	1.46e-06	6.09e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—EP300—systemic lupus erythematosus	1.21e-06	5.07e-05	CbGpPWpGaD
